Statistics for The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis
Total visits
| views | |
|---|---|
| The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis | 194 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms973526.pdf | 185 |
Top country views
| views | |
|---|---|
| United States | 143 |
| Germany | 7 |
| United Kingdom | 5 |
| Sweden | 5 |
| Ukraine | 5 |
| Canada | 2 |
| China | 1 |
| France | 1 |
| Japan | 1 |
| South Korea | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 45 |
| Fairfield | 24 |
| Houston | 11 |
| Cambridge | 8 |
| Falls Church | 8 |
| White Plains | 7 |
| Jacksonville | 6 |
| Kiev | 5 |
| Kiez | 5 |
| San Francisco | 5 |
| Stockholm | 4 |
| Ann Arbor | 2 |
| Baltimore | 2 |
| Chicago | 2 |
| Evanston | 2 |
| Gunzenhausen | 2 |
| Toronto | 2 |
| Beijing | 1 |
| Brooklyn | 1 |
| City of Westminster | 1 |
| Kista | 1 |
| Lafayette | 1 |
| Leiden | 1 |
| Notre Dame | 1 |
| Roubaix | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seoul | 1 |
| Seremban | 1 |
| Trumbull | 1 |
| Zheleznogorsk | 1 |